Healthcare provider profile · identity verified

Daimis Vazquez Rosabal, MD

General Practice · MIAMI, FL · NPI 1124422522

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	551	195
Losartan Potassium	Losartan Potassium	413	136
Metoprolol Succinate	Metoprolol Succinate	284	86
Amlodipine Besylate	Amlodipine Besylate	279	93
Lisinopril	Lisinopril	256	94
Metformin Hcl	Metformin Hcl	252	93
Omeprazole	Omeprazole	252	84
Levothyroxine Sodium	Levothyroxine Sodium	249	84
Gabapentin	Gabapentin	239	81
Rosuvastatin Calcium	Rosuvastatin Calcium	207	77
Famotidine	Famotidine	178	60
Eliquis	Apixaban	153	41
Hydrochlorothiazide	Hydrochlorothiazide	153	58
Pantoprazole Sodium	Pantoprazole Sodium	152	51
Diclofenac Sodium	Diclofenac Sodium	137	53
Latanoprost	Latanoprost	135	32
Tamsulosin Hcl	Tamsulosin Hcl	131	51
Albuterol Sulfate Hfa	Albuterol Sulfate	121	32
Alendronate Sodium	Alendronate Sodium	120	41
Glipizide Er	Glipizide	120	40
Escitalopram Oxalate	Escitalopram Oxalate	116	39
Donepezil Hcl	Donepezil Hcl	108	33
Furosemide	Furosemide	106	36
Alcohol Prep Pads	Alcohol Antiseptic Pads	104	29
Simvastatin	Simvastatin	102	36
Trazodone Hcl	Trazodone Hcl	92	44
Fenofibrate	Fenofibrate	87	39
Ketoconazole	Ketoconazole	82	23
Montelukast Sodium	Montelukast Sodium	77	24
Oxybutynin Chloride	Oxybutynin Chloride	76	23
Carvedilol	Carvedilol	75	23
Fluticasone Propionate	Fluticasone Propionate	75	28
Ammonium Lactate	Ammonium Lactate	71	24
Memantine Hcl	Memantine Hcl	71	20
Mirtazapine	Mirtazapine	71	22
Metoprolol Tartrate	Metoprolol Tartrate	69	24
Clopidogrel	Clopidogrel Bisulfate	67	26
Atenolol	Atenolol	64	23
Glimepiride	Glimepiride	63	19
Allopurinol	Allopurinol	62	20
Metformin Hcl Er	Metformin Hcl	62	24
Tradjenta	Linagliptin	58	18
Sertraline Hcl	Sertraline Hcl	57	13
Januvia	Sitagliptin Phosphate	56	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	18
Triamcinolone Acetonide	Triamcinolone Acetonide	54	16
Bumetanide	Bumetanide	49	16
Nifedipine Er	Nifedipine	44	15
Enalapril Maleate	Enalapril Maleate	43	16
Potassium Chloride	Potassium Chloride	40	13
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	37	12
Azithromycin	Azithromycin	35	34
Finasteride	Finasteride	34	11
Ibuprofen	Ibuprofen	34	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	11
Mupirocin	Mupirocin	34	23
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Baclofen	Baclofen	32	27
Ciclopirox	Ciclopirox	32	18
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	15
Irbesartan	Irbesartan	31	11
Clonidine Hcl	Clonidine Hcl	30	12
Pioglitazone Hcl	Pioglitazone Hcl	29	11
Farxiga	Dapagliflozin Propanediol	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Xarelto	Rivaroxaban	27	12
Glipizide	Glipizide	26	12
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Pentoxifylline	Pentoxifylline	23	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	22	suppressed
Prednisone	Prednisone	22	14
Janumet	Sitagliptin Phos/Metformin Hcl	21	suppressed
Lactulose	Lactulose	21	suppressed
Lumigan	Bimatoprost	21	suppressed
Valsartan	Valsartan	21	suppressed
Alcohol Swab	Alcohol Antiseptic Pads	20	17
Spironolactone	Spironolactone	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	13
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Temazepam	Temazepam	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	14
Methotrexate	Methotrexate Sodium	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Folic Acid	Folic Acid	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Metolazone	Metolazone	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Ozempic	Semaglutide	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error